Discussion
Hemochromatosis is a relatively common autosomal recessive disease, affecting one in 200 individuals of North European ancestry. 1 Various genetic defects are capable of causing it and all of them invariably affect the regulatory function of hepcidin through direct or indirect mechanisms. 1 Eighty percent of the afflicted people have a mutation of the HFE gene, located on chromosome 6. This disorder is characterized by increased iron absorption from the digestive tract, disproportionate entry of iron into the bloodstream in excess of what is required for normal erythropoiesis and, eventually, iron overload. This overload leads to widespread iron parenchymal deposition and increased oxidative stress, which ultimately causes multiple organ dysfunctions, including cardiomyopathy, arthritis, pancreatic disease with diabetes, liver failure and hypogonadism, among others, leading to reduced longevity. Early recognition and treatment to delay iron overload have been shown to improve survival. 1 Phlebotomy has been the standard treatment of hemochromatosis for 60 decades. Therapy consists on depleting total body iron stores by time consuming and life altering weekly to biweekly induction phlebotomies. Once the iron-deficiency state is achieved, serum ferritin values are monitored through time and maintenance phlebotomies are performed accordingly with a goal of maintaining ferritin <50 ng/ml (112.35 pmol/l). Despite its long time in use, there are no studies addressing the main issues surrounding phlebotomy therapy. No definite data exists on when therapy should be started, the frequency required, or uniform therapeutic goals, and there are no clear alternative treatments.
In this sense, iron-deficiency anemia occurs in 6-50% of patients who undergo gastric bypass surgery. 2 The reasons behind this are a decreased dietary intake of red meat, 3 decreased acid secretion and subsequent solubilization of ferric iron, 3 the exclusion of the duodenum by the particular procedure, 4 bacterial overgrowth and the induction of an iron-losing enteropathy. 5 In patients with hemochromatosis, this iron loss counteracts the overloading conditions, hypothetically decreasing or substituting the need for phlebotomies. Gastric bypass surgery can induce an iron-deficient state and could represent a novel intervention in the management of hemochromatosis in obese patients. Previous reports and the case that we describe suggest that.
Ott et al. 6 reported the case of a patient with hemochromatosis who, 2 years after Roux-en-Y gastric bypass, presented with normal serum iron, ferritin, TIBC and iron saturation levels, hence not requiring further treatment with phlebotomies. Similarly, Barton reports a series of three patients with hereditary hemochromatosis, C282Y homozygotes, who underwent bariatric surgery. 7 The interval between phlebotomies decreased dramatically for one of the patients, from one unit every $71 days to one unit every $173 days, thus decreasing the burden associated with therapy. Interestingly, the other two patients were diagnosed with hereditary hemochromatosis after undergoing bariatric surgery and did not develop iron overload. 7 These findings in these two patients could certainly be coincidental but would also hint to a protective role of the surgeries against iron overload. Furthermore, Kudva and Bacon report the case of a patient with hemochromatosis who developed severe iron-deficiency anemia secondary to both gastric bypass surgery and phlebotomy, 8 underscoring the importance of adjusting bloodletting therapy under these circumstances.
For the management of obese patients with hemochromatosis and C282Y homozygosity, we should consider that bariatric surgery may be acting as a factor that counterbalances increased iron entry with positive consequences. On the other hand, anemia is still a significant risk and larger series of cases are required to make a strong recommendation for this intervention. Finally, it would be prudent to withhold phlebotomy after surgery until serum ferritin levels exceed the upper reference limit.
In conclusion, gastric bypass surgery could be considered as new approach in the management 
